It is a real estate and construction private limited company based in New Delhi, Delhi, India, established in 1995.
1995 | New Delhi, Delhi, India | ActiveEuro Drugs Private Limited, a active private limited company, was established on 17 February 1995 in New Delhi, Delhi, India. Engaging in real estate marketing & sales within the real estate sector, it holds CIN: U74899DL1995PTC065553. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.60 M.
Formerly known as Euro Drugs Limited. It upholds a compliant status. Its leadership includes Preeti Aggarwal (Director), Mansi Aggarwal (Director). Past directors included Ram Kishore Aggarwal, Sunita Aggarwal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Grover Mansion 3/17, Asaf Ali Road,, New Delhi, Delhi, 110002.
U74899DL1995PTC065553
065553
17 February 1995
₹1.00 M
₹0.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Euro Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Aggarwal | Director | 17 Feb 1995 | Current |
| Mansi Aggarwal | Director | 30 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Apr 2012 | Past |
| Pramod Abcsdd | Director | 26 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Euro Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.48% increase. The company also saw a substantial improvement in profitability, with a 161.08% increase in profit. The company's net worth moved up by a moderate rise of 6.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Euro Drugs had a promoter holding of 59.58% and a public holding of 40.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Euro Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Euro Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euro Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Euro Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Euro Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Mansi Aggarwal was appointed as a Director was appointed as a Director on 30 Oct 2014 & has been associated with this company since 11 years 26 days . was recorded as a recent event.
Progress on Preeti Aggarwal was appointed as a Director was appointed as a Director on 17 Feb 1995 & has been associated with this company since 30 years 9 months . was documented.
The activity Euro Drugs Private Limited was registered on 17 Feb 1995 with Roc Delhi & aged 30 years 9 months as per MCA records. was completed.
The CIN of Euro Drugs Private Limited is U74899DL1995PTC065553.
Euro Drugs Private Limited is headquartered at Grover Mansion 3/17, Asaf Ali Road,, New Delhi, Delhi, 110002.
Euro Drugs Private Limited was incorporated on 17 February 1995.
The current directors of Euro Drugs Private Limited are
The primary industry of Euro Drugs Private Limited is Real Estate.
Euro Drugs Private Limited is unlisted.
The authorized capital of Euro Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.60 M.
The compliance status of Euro Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX